INDUSTRY EXPERT ARTICLES

Author Jon Gingrich, CEO, Echosens North America writes, “Nonalcoholic fatty liver disease (NAFLD) is an asymptomatic and underdiagnosed disease that affects 37% of U.S. adults and 70% of individuals with Type 2 diabetes. Nonalcoholic steatohepatitis (NASH), the more severe form of NAFLD marked by inflammation and ballooning, can lead to hepatic fibrosis, cirrhosis, and hepatocellular cancer (HCC) if left untreated.” Read more.

James A. Joyce writes, “On March 24, 2020, the U.S. Department of Health and Human Services declared that the emergence of COVID-19 justified the Emergency-Use Authorization of drugs, biological products, and medical devices to combat the pandemic. Read what he has to say.

Pauline Dinnauer is the VP of Audiological Care at Connect Hearing, which provides industry-leading hearing loss, hearing testing, and hearing aid consultation across the US. Read what she has to say.

Jesper Jonsson, Director of Medical Devices at Owen Mumford shares his thoughts on last year’s key sustainability topics and outlines how Owen Mumford is developing its own sustainability commitments. Read on.

Cochlear Limited has officially announced FDA approval and clearance for remote assist capabilities on several of its implants. Here’s what that means for you. Dr. Renee Flanagan is the Director of Audiological Care at Hearing Planet. Read more about what she has to say,

by Raimundo Sierra, Ph.D., Co-Founder, VirtaMed. He writes, “As the world continues to advance technologically, medical education must follow suit.”